A role of HAUSP in tumor suppression in a human colon carcinoma xenograft model.
Open accessAbstract
The protease HAUSP is a critical component of the p53-Mdm2 pathway and acts as a specific deubiquitinase for both p53 and Mdm2 and thus is important for p53 regulation. In knock-down and knock-out cellular systems it was observed that ablation of HAUSP induces profound stabilization of p53 due to enhanced degradation of Mdm2. Thus, inhibiting HAUSP by small compound interference has been proposed as a rational therapeutic strategy to activate p53 in p53 wild type tumors. However, HAUSP-mediated effects in the p53-Mdm2 axis are highly complex and non-linear and to date the role of HAUSP in tumor suppression in vivo remains unexplored. Here we investigate the effect of HAUSP up and downregulation on cell proliferation, apoptosis and tumor growth in vitro and in a xenograft model in vivo, using an inducible isogenic human colon carcinoma cell system. Importantly, in the absence of stress, both HAUSP up and downregulation inhibit cell proliferation in vitro and tumor growth in vivo due to constitutively elevated p53 levels. Moreover, tumors with HAUSP up and downregulation respond to radiotherapy with further growth inhibition. However, HAUSP downregulation causes resistance to Camptothecin- and irradiation-induced apoptosis, which correlates with suppressed mitochondrial translocation of p53. Our data suggest that changes in HAUSP modulate tumor growth and apoptotic sensitivity in vivo.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
One way USP7 inhibitors kill cancer cells is via stabilization of p53, resulting from degradation of Mdm2 in the absence of its USP7-mediated deubiquitination.
“One way through which this occurs is via the stabilization of p53, resulting from the degradation of Mdm2 in the absence of its USP7-mediated deubiquitination (Li et al., 2002, 2004; Cummins et al., 2004; Becker et al., 2008; Kategaya et al., 2017).”
From USP7 Is a Master Regulator of Genome Stability (2020) · cites this paper as Becker et al., 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100 · see citing works
The p53-mdm-2 autoregulatory feedback loop.
Wu, X., Bayle, J. H., Olson, D., & Levine, A. J. (1993) · Genes & Development · doi:10.1101/gad.7.7a.1126 · Cited by 1,801 · see citing works
p53 Has a Direct Apoptogenic Role at the Mitochondria
Mihara, M., Erster, S. H., Zaika, A. I., Petrenko, O., Chittenden, T. D., Pančoška, P., & Moll, U. M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00050-9 · Cited by 1,771 · see citing works
Self-citationRecognition of the polyubiquitin proteolytic signal
Thrower, J. S., Hoffman, L. M., Rechsteiner, M., & Pickart, C. M. (2000) · The EMBO Journal · doi:10.1093/emboj/19.1.94 · Cited by 1,718 · see citing works
Post‐translational modifications and activation of p53 by genotoxic stresses
Appella, E., & Anderson, C. W. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02225.x · Cited by 1,071 · see citing works
Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization
Li, M., Chen, D., Shiloh, A., Luo, J., Nikolaev, A. Y., Qin, J., & Gu, W. J. (2002) · Nature · doi:10.1038/nature737 · Cited by 1,027 · see citing works
p53 ubiquitination: Mdm2 and beyond
Brooks, C. L., & Gu, W. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.01.020 · Cited by 924 · see citing works
Death Signal-induced Localization of p53 Protein to Mitochondria
Marchenko, N. D., Zaika, A. I., & Moll, U. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.21.16202 · Cited by 902 · see citing works
Self-citationMono- Versus Polyubiquitination: Differential Control of p53 Fate by Mdm2
Li, M., Brooks, C. L., Wu-Baer, F., Chen, D., Baer, R., & Gu, W. (2003) · Science · doi:10.1126/science.1091362 · Cited by 804 · see citing works
A dynamic role of HAUSP in the p53-Mdm2 pathway
Li, M., Brooks, C. L., Kon, N., & Gu, W. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00157-1 · Cited by 679 · see citing works
Cell Cycle Inhibition by FoxO Forkhead Transcription Factors Involves Downregulation of Cyclin D
Schmidt, M., de Mattos, S. F., van der Horst, A., Klompmaker, R., Kops, G. J. P. L., Lam, E. W. ‐., Burgering, B. M. T., & Medema, R. H. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.22.7842-7852.2002 · Cited by 566 · see citing works
FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP
van der Horst, A., de Vries-Smits, A. M. M., Brenkman, A. B., van Triest, M. H., van den Broek, N. J. F., Colland, F., Maurice, M. M., & Burgering, B. M. T. (2006) · Nature Cell Biology · doi:10.1038/ncb1469 · Cited by 479 · see citing works
Polyubiquitination of p53 by a Ubiquitin Ligase Activity of p300
Grossman, S. R., Deato, M. D. E., Brignone, C., Chan, H. M., Kung, A. L., Tagami, H., Nakatani, Y., & Livingston, D. M. (2003) · Science · doi:10.1126/science.1080386 · Cited by 454 · see citing works
Multiple C-Terminal Lysine Residues Target p53 for Ubiquitin-Proteasome-Mediated Degradation
Rodríguez, M. S., Desterro, J. M. P., Laı́n, S., Lane, D. P., & Hay, R. T. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.22.8458-8467.2000 · Cited by 386 · see citing works
Disruption of HAUSP gene stabilizes p53.
Cummins, J. M., Rago, C., Kohli, M., Kinzler, K. W., Lengauer, C., & Vogelstein, B. (2004) · Nature · doi:10.1038/nature02501 · Cited by 379 · see citing works
Erster, S. H., Mihara, M., Kim, R. H., Petrenko, O., & Moll, U. M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.15.6728-6741.2004 · Cited by 367 · see citing works
Self-citationMolecular recognition of p53 and MDM2 by USP7/HAUSP.
Sheng, Y., Saridakis, V., Sarkari, F., Duan, S., Wu, T., Arrowsmith, C. H., & Frappier, L. (2006) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1067 · Cited by 315 · see citing works
Monoubiquitylation promotes mitochondrial p53 translocation
Marchenko, N. D., Wolff, S., Erster, S., Becker, K., & Moll, U. M. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601560 · Cited by 286 · see citing works
Self-citationHermani, A., DESERVI, B., Medunjanin, S., Tessier, P. A., & Mayer, D. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.10.013 · Cited by 262 · see citing works
Meulmeester, E., Maurice, M. M., Boutell, C., Teunisse, A. F. A. S., Ovaa, H., Abraham, T. E., Dirks, R. W., & Jochemsen, A. G. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.04.024 · Cited by 260 · see citing works
Cross, S. S., Hamdy, F. C., Deloulme, J., & Rehman, I. (2005) · Histopathology · doi:10.1111/j.1365-2559.2005.02097.x · Cited by 259 · see citing works
Hu, M., Gu, L., Li, M., Jeffrey, P. D., Gu, W., & Shi, Y. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0040027 · Cited by 251 · see citing works
Nakamura, S., Roth, J. A., & Mukhopadhyay, T. K. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.24.9391-9398.2000 · Cited by 198 · see citing works
Hypoxia death stimulus induces translocation of p53 protein to mitochondria
Sansome, C., Zaika, A., Marchenko, N. D., & Moll, U. M. (2001) · FEBS Letters · doi:10.1016/s0014-5793(00)02368-1 · Cited by 174 · see citing works
Self-citationRinaldo, C., Prodosmo, A., Mancini, F., Iacovelli, S., Sacchi, A., Moretti, F., & Soddu, S. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.02.008 · Cited by 172 · see citing works
ATM-Mediated Phosphorylations Inhibit Mdmx/Mdm2 Stabilization by HAUSP in Favor of p53 Activation
Meulmeester, E., Pereg, Y., Shiloh, Y., & Jochemsen, A. G. (2005) · Cell Cycle · doi:10.4161/cc.4.9.1981 · Cited by 166 · see citing works
The p53–Mdm2–HAUSP complex is involved in p53 stabilization by HAUSP
Brooks, C. L., Li, M., Hu, M., Shi, Y., & Gu, W. (2007) · Oncogene · doi:10.1038/sj.onc.1210531 · Cited by 144 · see citing works
Masuya, D., Huang, C., Liu, D., Nakashima, T., Yokomise, H., Ueno, M., Nakashima, N., & Sumitomo, S. (2006) · The Journal of Pathology · doi:10.1002/path.1931 · Cited by 103 · see citing works
The Role of Ubiquitination in the Direct Mitochondrial Death Program of p53
Marchenko, N. D., & Moll, U. M. (2007) · Cell Cycle · doi:10.4161/cc.6.14.4503 · Cited by 73 · see citing works
Self-citationHyperubiquitylation of wild-type p53 contributes to cytoplasmic sequestration in neuroblastoma
Becker, K., Marchenko, N. D., Maurice, M. M., & Moll, U. M. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402126 · Cited by 53 · see citing works
Self-citationProteome Changes Induced by Knock-Down of the Deubiquitylating Enzyme HAUSP/USP7
Kessler, B. M., Fortunati, E., Melis, M. H. M., Pals, C. E. G. M., Clevers, H. C., & Maurice, M. M. (2007) · Journal of Proteome Research · doi:10.1021/pr0702161 · Cited by 47 · see citing works
HAUSP as a therapeutic target for hematopoietic tumors (review)
Cheon, K., & Baek, K. (2006) · International Journal of Oncology · doi:10.3892/ijo.28.5.1209 · Cited by 37 · see citing works
Lim, S.-K., Shin, J. A., Kim, Y., & Baek, K. (2004) · International Journal of Oncology · doi:10.3892/ijo.24.2.357 · Cited by 30 · see citing works
HAUSP-regulated switch from auto- to p53 ubiquitination by Mdm2 (in silico discovery)
Brazhnik, P., & Kohn, K. W. (2007) · Mathematical Biosciences · doi:10.1016/j.mbs.2007.05.005 · Cited by 13 · see citing works
Expression and functional analyses of mHAUSP regulating apoptosis of cervical adenocarcinoma cells
Yoo, K., Lee, H.-J., Lee, H., Lee, K.-Y., Lee, S., Chung, H., & Baek, K. (2005) · International Journal of Oncology · doi:10.3892/ijo.27.1.97 · Cited by 12 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- Marchenko ND, Zaika A, Moll UM. Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling. J Biol Chem 2000; 275:16202-12.
Cited by
Sorted by citations
Role of p53 in Cell Death and Human Cancers
Ozaki, T., & Nakagawara, A. (2011) · Cancers · doi:10.3390/cancers3010994 · Cited by 743 · see citing works
Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells
Colland, F., Formstecher, É., Jacq, X., Reverdy, C., Planquette, C., Conrath, S., Trouplin, V., Bianchi, J., Aushev, V. N., Camonis, J., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0097 · Cited by 322 · see citing works
Discovery of specific inhibitors of human USP7/HAUSP deubiquitinating enzyme.
Reverdy, C., Conrath, S., Lopez, R., Planquette, C., Atmanene, C., Collura, V., Harpon, J., Battaglia, V., Vivat, V., Sippl, W., et al. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.02.007 · Cited by 270 · see citing works
Faesen, A. C., Dirac, A. M. G., Shanmugham, A., Ovaa, H., Anastassis Perrakis, A., & Sixma, T. K. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.06.034 · Cited by 251 · see citing works
Brooks, C. L., & Gu, W. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.05.022 · Cited by 186 · see citing works
Inactivation of HAUSP in vivo modulates p53 function.
Kon, N., Kobayashi, Y., Li, M., Brooks, C. L., Ludwig, T., & Gu, W. (2010) · Oncogene · doi:10.1038/onc.2009.427 · Cited by 176 · see citing works
Emerging insights into HAUSP (USP7) in physiology, cancer and other diseases.
Bhattacharya, S., Chakraborty, D., Basu, M., & Ghosh, M. K. (2018) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-018-0012-y · Cited by 162 · see citing works
Qi, S., Cheng, G., Cheng, X., Xu, Z., Xu, B., Zhang, W., & Qin, J. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00233 · Cited by 162 · see citing works
Deubiquitinases and the new therapeutic opportunities offered to cancer
Pfoh, R., Lacdao, I. K., & Saridakis, V. (2015) · Endocrine Related Cancer · doi:10.1530/erc-14-0516 · Cited by 140 · see citing works
USP7: Novel Drug Target in Cancer Therapy
Wang, Z., Kang, W.-T., You, Y., Pang, J., Ren, H., Suo, Z., Liu, H., & Zheng, Y. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00427 · Cited by 124 · see citing works
The therapeutic potential of deubiquitinating enzyme inhibitors
Colland, F. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380137 · Cited by 124 · see citing works
USP7 Is a Master Regulator of Genome Stability
Valles, G. J., Bezsonova, I., Woodgate, R., & Ashton, N. W. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00717 · Cited by 114 · see citing works
“One way through which this occurs is via the stabilization of p53, resulting from the degradation of Mdm2 in the absence of its USP7-mediated deubiquitination (Li et al., 2002, 2004; Cummins et al., 2004; Becker et al., 2008; Kategaya et al., 2017).”
BackgroundUbiquitin becomes ubiquitous in cancer
Shi, D., & Grossman, S. R. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.8.13417 · Cited by 118 · see citing works
Pozhidaeva, A., Valles, G., Wang, F., Wu, J., Sterner, D. E., Nguyen, P., Weinstock, J., Kumar, K. G. S., Kanyo, J., Wright, D., et al. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.09.004 · Cited by 107 · see citing works
Modulation of the p53/MDM2 interplay by HAUSP inhibitors
Tavana, O., & Gu, W. J. (2016) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjw049 · Cited by 108 · see citing works
Regulation of pluripotency and differentiation by deubiquitinating enzymes
Suresh, B., Lee, J., Kim, S., & Ramakrishna, S. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.53 · Cited by 93 · see citing works
The emerging nature of Ubiquitin-specific protease 7 (USP7): a new target in cancer therapy
Nininahazwe, L., Liu, B., He, C., Zhang, H., & Chen, Z. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.10.028 · Cited by 92 · see citing works
Di Lello, P., Pastor, R., Murray, J. M., Blake, R. A., Cohen, F., Crawford, T. D., Drobnick, J., Drummond, J., Kategaya, L., Kleinheinz, T., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01293 · Cited by 90 · see citing works
Issaenko, O. A., & Amerik, A. Y. (2012) · Cell Cycle · doi:10.4161/cc.20174 · Cited by 81 · see citing works
The role of UBL domains in ubiquitin-specific proteases
Faesen, A. C., Luna‐Vargas, M. P. A., & Sixma, T. K. (2012) · Biochemical Society Transactions · doi:10.1042/bst20120004 · Cited by 66 · see citing works
Expression of HAUSP in gliomas correlates with disease progression and survival of patients
Cheng, C., Niu, C., Yang, Y., Wang, Y., & Lu, M. (2013) · Oncology Reports · doi:10.3892/or.2013.2342 · Cited by 61 · see citing works
HAUSP , a novel deubiquitinase for Rb – MDM 2 the critical regulator
Bhattacharya, S., & Ghosh, M. K. (2014) · FEBS Journal · doi:10.1111/febs.12843 · Cited by 57 · see citing works
Targeting Ubiquitin-Specific Protease 7 (USP7) in Cancer: A New Insight to Overcome Drug Resistance
Lu, J., Zhao, H., Yu, C., Kang, Y., & Yang, X. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.648491 · Cited by 59 · see citing works
The USP7 protein interaction network and its roles in tumorigenesis
Al-Eidan, A., Wang, Y., Skipp, P., & Ewing, R. M. (2022) · Genes & Diseases · doi:10.1016/j.gendis.2020.10.004 · Cited by 57 · see citing works
CDDO-Me reveals USP7 as a novel target in ovarian cancer cells
Qin, D., Wang, W., Lei, H., Luo, H., Cai, H., Tang, C., Wu, Y., Wang, Y., Jin, J., Xiao, W., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12801 · Cited by 54 · see citing works
Recent advances on the intervention sites targeting USP7-MDM2-p53 in cancer therapy
Harakandi, C., Nininahazwe, L., Xu, H., Liu, B., He, C., Zheng, Y., & Zhang, H. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.105273 · Cited by 52 · see citing works
Gowdhami, B., Ambika, S., Balakrishnan, K., Ramya, V., Kadalmani, B., Vimala, R. T. V., & Akbarsha, M. A. (2021) · Toxicology in Vitro · doi:10.1016/j.tiv.2021.105201 · Cited by 47 · see citing works
HAUSP-nucleolin interaction is regulated by p53-Mdm2 complex in response to DNA damage response
Lim, K., Park, J.-J., Gu, B., Kim, J.-O., Park, S. G., & Baek, K. (2015) · Scientific Reports · doi:10.1038/srep12793 · Cited by 42 · see citing works
Coombs, N., Sompallae, R. R., Olbermann, P., Gastaldello, S., Göppel, D., Masucci, M. G., & Josenhans, C. (2010) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2010.09.004 · Cited by 36 · see citing works
HAUSP regulates c-MYC expression via de-ubiquitination of TRRAP
Bhattacharya, S., & Ghosh, M. K. (2015) · Cellular Oncology · doi:10.1007/s13402-015-0228-6 · Cited by 31 · see citing works
USP7 facilitates SMAD3 autoregulation to repress cancer progression in p53-deficient lung cancer
Huang, Y.-T., Cheng, A.-C., Tang, H.-C., Huang, G.-C., Cai, L., Lin, T.-H., Wu, K.-J., Tseng, P., Wang, G. G., & Chen, W. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04176-8 · Cited by 32 · see citing works
Gao, L., Zhu, D., Wang, Q., Bao, Z., Yin, S., Qiang, H., Wieland, H., Zhang, J., Teichmann, A. T., & Jia, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.650165 · Cited by 29 · see citing works
Liu, S., Zhou, X., Li, M., Zhao, W., Zhou, S., Cheng, K., Xu, Q., Chen, C., Wen, X., Sun, H., et al. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00154 · Cited by 28 · see citing works
Zhou, L., Ouyang, T., Li, M., Hong, T., Alriashy, M. H. S., Meng, W., & Zhang, N. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.784672 · Cited by 23 · see citing works
USP7 substrates identified by proteomics analysis reveal the specificity of USP7Preprint
Nie, L., Wang, C., Liu, X., Teng, H., Li, S., Huang, M., Feng, X., Pei, G., Hang, Q., Zhao, Z., et al. (2022) · Genes & Development · doi:10.1101/gad.349848.122 · Cited by 24 · see citing works
E3 Ubiquitin Ligase in Anticancer Drugdsla Resistance: Recent Advances and Future Potential
Liu, Y., Duan, C., & Zhang, C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.645864 · Cited by 22 · see citing works
Pro-apoptotic and anti-apoptotic regulation mediated by deubiquitinating enzymes
Choi, H., & Baek, K. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04132-5 · Cited by 27 · see citing works
A review of deubiquitinases and thier roles in tumorigenesis and development
Liang, X.-W., Wang, S.-Z., Liu, B., Chen, J.-C., Cao, Z. W., Chu, F.-R., Xiong, L., Liu, H., & Wu, J. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1204472 · Cited by 20 · see citing works
Collaud, S., Tischler, V., Atanassoff, A., Wiedl, T., Komminoth, P., Oehlschlegel, C., Weder, W., & Soltermann, A. (2015) · BMC Cancer · doi:10.1186/s12885-015-1084-5 · Cited by 18 · see citing works
Villacis, R. A. R., de Miranda, P. M., Gomy, I., Santos, É. M. M., Carraro, D. M., Achatz, M. I., Rossi, B. M., & Rogatto, S. R. (2015) · International Journal of Cancer · doi:10.1002/ijc.29948 · Cited by 15 · see citing works
Oveland, E., Gjertsen, B. T., Wergeland, L., Selheim, F., Fladmark, K. E., & Hovland, R. (2008) · Leukemia Research · doi:10.1016/j.leukres.2008.06.029 · Cited by 15 · see citing works
Clorennec, C. L., Lee, K. S., Huo, Y., & Zage, P. E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813780 · Cited by 14 · see citing works
Regulating the Master Regulator: Controlling Ubiquitination by Thinking Outside the Active Site
Paiva, S.-L., da Silva, S. R., de Araujo, E. D., & Gunning, P. T. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01346 · Cited by 13 · see citing works
STIP is a critical nuclear scaffolding protein linking USP7 to p53-Mdm2 pathway regulation
Ye, M., Tang, Y.-N., Tang, S.-J., Liu, J., Wu, K., Yao, S., Sun, Y., Zhou, L. J., Deng, T., Chen, Y., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5303 · Cited by 12 · see citing works
Future Cancer Therapy with Molecularly Targeted Therapeutics: Challenges and Strategies
Kim, M.-S. (2011) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2011.19.4.371 · Cited by 10 · see citing works
Walker, C. W., Low, B., & Böttger, S. A. (2012) · Springer eBooks · doi:10.1007/978-94-007-3027-4_6 · Cited by 10 · see citing works
Al-Balushi, E., Marzouqi, A. M. A., Tavoosi, S., Baghsheikhi, A. H., Sadri, A., Aliabadi, L. S., Salarabedi, M.-M., Rahman, S. A., Al‐Yateem, N., Jarrahi, A. M., et al. (2024) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v16.i1.197 · Cited by 8 · see citing works
Pawlak, A., Bajzert, J., Bugiel-Stabla, K., Suárez, B. H., Kutkowska, J., Rapak, A., Hildebrand, W., Obmińska‐Mrukowicz, B., Freire, R., & Smits, V. A. J. (2021) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.16082 · Cited by 6 · see citing works
USP7 Deregulation Impairs S Phase Specific DNA Repair after Irradiation in Breast Cancer Cells
Vogt, M., Classen, S., Krause, A. K., Peter, N.-J., Petersen, C., Rothkamm, K., Borgmann, K., & Meyer, F. B. (2024) · Biomedicines · doi:10.3390/biomedicines12040762 · Cited by 4 · see citing works
Lello, P. D., Rougé, L., Pan, B., & Maurer, T. (2016) · Biomolecular NMR Assignments · doi:10.1007/s12104-016-9698-3 · Cited by 4 · see citing works
Discovery of indane and naphthalene derivatives as USP7 inhibitors
Zhang, X., Tan, S., Wang, D., Zhu, H., Chen, D., Chen, Y., Wu, G., Zhu, Z., Zhang, F., Li, X., et al. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117824 · Cited by 2 · see citing works
Li, X., Wang, Y., Li, X., Liu, B., Zhao, Q., Li, W., Chen, S., Huang, X., Yang, F., Wang, Q., et al. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.5.1749 · Cited by 1 · see citing works
Al-Eidan, A. A., Draper, B., Wang, S., Coke, B., Skipp, P. J. S., Wang, Y., & Ewing, R. M. (2024) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2024.100878 · Cited by 1 · see citing works
Plessl, T. (2013) · University of Vienna · doi:10.25365/thesis.27688
Deubiquitinating Enzymes as Novel Targets for Cancer Therapies
Baek, K., Lim, K., & Park, J.-J. (2014) · Resistance to targeted anti-cancer therapeutics · doi:10.1007/978-3-319-06752-0_15
Pozhidaeva, A. (2016) · OpenCommons at University of Connecticut (University of Connecticut)
Silvestrini, V. C. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2019.tde-30052019-162011
USP7 regulates melanoma progression through PI3K/Akt/FOXO and AMPK PathwaysPreprint
Teichmann, A. T., Jia, J., Gao, L., Zhu, D., Wang, Q., Yin, S., Qiang, H., Wieland, H., Zhang, J., & Bao, Z. (2020) · doi:10.21203/rs.3.rs-24933/v1
Deubiquitinases as novel therapeutic targets in colorectal cancer
Shukri, N. A., & Momin, R. B. A. (2025) · Asia-Pacific Journal of Oncology · doi:10.32948/ajo.2025.02.19
Jacomin, A. (2014) · doi:10.70675/f3bfc88eza395z447dz885dz5c9ec5838dbf
Fonctions et régulations de la kinase CHK1 dans l'hématopoïèse normale et leucémique
Cartel, M. (2019) · theses.fr (ABES) · doi:10.70675/7824b06fz5467z4c2cz89c1zf5bed2a53f34
Qi, W., Ren, R., Yu, L., Cao, L., Zhang, J., Wang, X., Li, Q., Yang, W., Zhang, C., & Zhang, M. (2026) · Cell Death and Differentiation · doi:10.1038/s41418-026-01827-1
- Authors
- Becker, K., Marchenko, N., Palacios, G., & Moll, U. M.
- Affiliations
- Stony Brook University (US)
- University of Göttingen (DE)
- Venue
- Cell Cycle
- Publisher
- Informa UK Limited
- Published
- 2008-05
- Volume
- 7
- Issue
- 9
- Pages
- 1205-1213
- ISSN
- 1538-4101 (ISSN-L)
- 1551-4005
- PMC
- PMC3873824
- OpenAlex
- W1996657349
- Cited by
- 63
- References
- 35
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 2 · 2022: 2 · 2021: 8 · 2020: 6 · 2019: 3 · 2018: 1 · 2017: 3 · 2016: 5 · 2015: 6 · 2014: 3 · 2013: 2 · 2012: 5
- FWCI
- 1.94
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cell Cycle (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA060664)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- USP7, p53, MDM2, deubiquitinase, colon cancer, tumor suppression, xenograft models, apoptosis, radiosensitivity, camptothecin resistance, cell proliferation
- MeSH terms
- Ubiquitin-Specific Peptidase 7, Animals, Carcinoma, Colonic Neoplasms, Disease Models, Animal, Humans, Mice, Nude, Neoplasm Invasiveness, Radiotherapy, Down-Regulation, Up-Regulation, Tumor Suppressor Protein p53, Apoptosis, Drug Resistance, Neoplasm, Protein Transport, Xenograft Model Antitumor Assays, Tumor Suppressor Proteins, Ubiquitin Thiolesterase, Cell Line, Tumor, Cell Proliferation, Mice, Proto-Oncogene Proteins c-mdm2, Ubiquitination
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
